Sort
34,240 grants matching “atherosclerosis”
Risk prediction of atrial fibrillation: clinical, biological and genetic markers
$492,694Emelia J. Benjamin · Boston University Medical Campus · RC1 · FY2009 · HL
Inducible Macrophage Specific Gene Expression in Diseases
$492,404Jeanine M D'armiento · Columbia University Health Sciences · RC1 · FY2010 · HL
Diabetes, Cognition and the Brain
$492,400Antonio Convit · New York University School Of Medicine · R01 · FY2012 · DK
Diabetes, Cognition and the Brain
$492,400Antonio Convit · New York University School Of Medicine · R01 · FY2011 · DK
STRESS REDUCTION AND CVD MORBIDITY AND MORTALITY IN BLACKS-II
$492,385Maharishi University Of Management · R01 · FY2005 · HL
Role of PPARs and PPARy In Atherosclerosis
$492,375Ronald M. Evans · University Of California, San Diego · P01 · FY2008 · HL
MANIPULATION OF THE NOS PATHWAY IN ARTERIAL DISEASE
$492,343Stanford University · R01 · FY2004 · HL
Endothelial dysfunction in aged Trx-deficient mice.
$492,215Kumuda C Das · Univ Of Arkansas For Med Scis · R01 · FY2011 · HL
Changes in Cardiovascular Control Mechanisms Related to Binge Drinking during College
$492,122Jennifer F. Buckman · Rutgers, The State Univ Of N.J. · R01 · FY2018 · AA
AMPK and adipose tissue biology in bariatric surgery patients
$492,069Neil B Ruderman · Boston Medical Center · R24 · FY2012 · DK
Modulation of Innate Immune Responses by Cytomegalovirus
$492,000Klaus J Frueh · Oregon Health & Science University · R01 · FY2009 · AI
15/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
$491,948Michelle Fischmann Magee · Medstar Health Research Institute · U01 · FY2018 · DK
Molecular predictors of resistance and vulnerability to cardiovascular events in stable ischemic heart disease
$491,905Jonathan D Newman · New York University School Of Medicine · R56 · FY2021 · HL
Fetal Determinants of Atherosclerosis
$491,898University Of California San Diego · R01 · FY2003 · HL
Novel Role of Thrombospondin-1 in Protection against Rupture of Abdominal Aortic Aneurysm
$491,881Bo Liu · University Of Wisconsin-Madison · R01 · FY2024 · HL
Long Term DPP Follow-Up Study
$491,792Robert E Ratner · Medstar Health Research Institute · U01 · FY2006 · DK
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stability
$491,772Michael V Autieri · Temple Univ Of The Commonwealth · R01 · FY2020 · HL
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stability
$491,772Michael V Autieri · Temple Univ Of The Commonwealth · R01 · FY2019 · HL
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stability
$491,772Michael V Autieri · Temple Univ Of The Commonwealth · R01 · FY2021 · HL
Attenuation of atherosclerosis by regulation of VSMC inflammatory gene mRNA stability
$491,772Michael V Autieri · Temple Univ Of The Commonwealth · R01 · FY2018 · HL
Siglec-targeted nanoparticles for lung and cardiovascular disease
$491,600James C. Paulson · Johns Hopkins University · P01 · FY2017 · HL
Interactions between oral pathogens and vascular cells
$491,591Ann Progulske-Fox · University Of Florida · R01 · FY2007 · DE
Hepatocyte Abca1, cholesterol trafficking, and lipid mobilization
$491,586John S Parks · Wake Forest University Health Sciences · R01 · FY2020 · HL
Contributions of Hepatic and Intestinal Pathways to Cholesterol Excretion
$491,578Gregory A Graf · University Of Kentucky · R01 · FY2025 · DK
Genotoxic Stress, Atherosclerosis and Metabolic Syndrom
$491,572Clay F. Semenkovich · Washington University · P50 · FY2006 · HL